Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat for GVHD Prevention in Reduced Intensity Allogeneic Transplant
NCT00810602Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Apr 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in graft-versus-host disease (GVHD). Started Jan 2009; status: completed.
02
Drugs
vorinostat
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00810602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810602.